You just read:

BiondVax Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate is Safe and Well Tolerated

News provided by

BiondVax Pharmaceuticals Ltd.

29 Nov, 2016, 07:30 ET